title: Cystinosis encephalopathy: MRI perivascular enhancement with micronodular T2* hypointensity.
authors.forename: X
authors.initials: X
authors.lastname: Cazals
authors.forename: M-A
authors.initials: MA
authors.lastname: Lauvin
authors.forename: O
authors.initials: O
authors.lastname: Favelle
authors.forename: F
authors.initials: F
authors.lastname: Domengie
authors.forename: H
authors.initials: H
authors.lastname: Nivet
authors.forename: J-P
authors.initials: JP
authors.lastname: Cottier
mesh_terms: D001921:Brain / Q000187:drug effects / Q000473:pathology; D020739:Brain Diseases, Metabolic, Inborn / Q000175:diagnosis* / Q000188:drug therapy; D002536:Cerebral Arteries / Q000473:pathology; D002648:Child; D003543:Cysteamine / Q000627:therapeutic use; D003554:Cystinosis / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D007090:Image Interpretation, Computer-Assisted / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D055118:Medication Adherence; D009460:Neurologic Examination
chemical_list: D007166:Immunosuppressive Agents; D003543:Cysteamine